The Correlation between Newborn Thyroid Stimulating Hormone with Maternal Urine Iodine Levels and the Assessment of Iodine Status in the Population during 2019

The Correlation between Newborn Thyruid Stimulating Hormone with Maternal Urine Iodine Levels

Authors

  • Hansa Thaisri Medical Life Science Institute, Department of Medical Sciences
  • Piamnukul Krasao Medical Life Science Institute, Department of Medical Sciences
  • Penpan Thong-ngao Medical Life Science Institute, Department of Medical Sciences
  • Supaporn Nammoonnoy Medical Life Science Institute, Department of Medical Sciences
  • Thippawan Kornsiripanya Medical Life Science Institute, Department of Medical Sciences
  • Napaphan Viriyautsahakul Bureau of Nutrition, Department of Health
  • Nuntaya Chongchaithe Bureau of Nutrition, Department of Health
  • Jutharat Supanuwat Bureau of Nutrition, Department of Health
  • Surakameth Mahasirimongkol Information and Communication Technology Center Office of the Permanent Secretary, Ministry of Public Health

Keywords:

Iodine deficiency, Maternal urine iodine, Newborn thyroid stimulating hormone

Abstract

         Iodine is a fundamental element for thyroid hormone synthesis, crucial for infant development and growth from prenatal stages. This study investigated the correlation between newborn thyroid-stimulating hormone (TSH) levels and maternal urine iodine (UI) concentrations in 2,471 maternal-child pairs across 25 provinces in Thailand in 2019 (B.E. 2562). Spearman's correlation analysis showed no significant relationship (r = -0.024, p-value = 0.233). The assessment of adequate iodine intake at the population level, as per WHO criteria (median urinary iodine, MUI ≥ 150 μg/L) and < 3% of newborns with TSH > 11.2 mU/L (5.0 mU/L in blood) was conducted. Among 4,395 pregnant women, MUI was 156.7 μg/L, suggesting sufficient iodine intake. However, 11.3% of newborns exhibited TSH levels > 11.2 mU/L, indicating iodine deficiency. Utilizing TSH levels for assessment might be inappropriate due to the timing of blood sample collection, mainly at 48−72 hours after birth when TSH levels are not normalized. Additionally, from 2023 onwards, congenital hypothyroidism screening for Thailand will be carried out by 10 laboratories using diverse technologies, reagent kits and TSH cutoff values to track babies. Therefore, relying on TSH levels from newborn hypothyroidism screening for regional iodine status assessment in Thailand is discouraged.

References

Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions. Endocr Rev 2010; 31(2): 139-70.

Williams GR. Neurodevelopmental and neurophysiological actions of thyroid hormone. J Neuroendocrinol 2008; 20(6): 784-94.

Kogai T, Taki K, Brent GA. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. Endocr Relat Cancer 2006; 13(3): 797-826.

Chawanpaiboon S, Titapant V. A randomized controlled trial of the correlation between iodine supplementation in pregnancy and maternal urine iodine and neonatal thyroid stimulating hormone levels. Siriraj Med J 2019; 71(1): 59-65.

WHO, UNICEF, ICCIDD. Assessment of the iodine deficiency disorders and monitoring their elimination: a guide for programme managers. 3rd ed. Geneva: World Health Organization; 2007.

WHO. Urinary iodine concentrations for determining iodine status deficiency in populations. Geneva: World Health Organization; 2013.

Glinoer D. The regulation of thyroid function during normal pregnancy: importance of the iodine nutrition status. Best Pract Res Clin Endocrinol Metab 2004; 18(2): 133-52.

de Escobar GM, Obregón MJ, del Rey FE. Maternal thyroid hormones early in pregnancy and fetal brain development. Best Pract Res Clin Endocrinol Metab 2004; 18(2): 225-48.

Ng SM, Wong SC, Paize F, Chakkarapani E, Newland P, Isherwood D, et al. Multivariate analyses of factors that affect neonatal screening thyroid stimulating hormone. J Pediatr Endocrinol Metab 2011; 24(9-10): 727-32.

นภาพรรณ วิริยะอุตสาหกุล, บรรณาธิการ. รายงานการศึกษาผลของการให้ยาเม็ดเสริมไอโอดีนต่อภาวะโภชนาการไอโอดีนในหญิงตั้งครรภ์. นนทบุรี: สำนักโภชนาการ กรมอนามัย กระทรวงสาธารณสุข; 2562.

Pino S, Fang SL, Braverman LE. Ammonium persulfate: a safe alternative oxidizing reagent for measuring urinary iodine. Clin Chem 1996; 42(2): 239-43.

Ohashi T, Yamaki M, Pandav CS, Karmarkar MG, Irie M. Simple microplate method for determination of urinary iodine. Clin Chem 2000; 46(4): 529-36.

ศูนย์ปฏิบัติการตรวจคัดกรองสุขภาพทารกแรกเกิดแห่งชาติ กรมวิทยาศาสตร์การแพทย์. สถิติการตรวจคัดกรอง 2539-65. [ออนไลน์]. 2565; [สืบค้น 17 มี.ค. 2566]; [3 หน้า]. เข้าถึงได้ที่: URL: https://www.neoscreen.go.th/index.php/th/screening/statistic-64.

เปี่ยมนุกูล กระเสาร์, เพ็ญพรรณ ทองเงา, จารณี พึ่งโพธิ์สภ, วิยะดา เจริญศิริวัฒน์, หรรษา ไทยศรี, อาชวินทร์ โรจนวิวัฒน์. ภาวะพร่องไทรอยด์ฮอร์โมนแต่กำเนิดในทารกแรกเกิดใน 4 ภูมิภาคของประเทศไทยช่วงปี พ.ศ. 2559 ถึง 2561. ว กรมวิทย พ 2564; 63(2): 259-74.

Skeaff SA, Thomson CD, Wilson N, Parnell WR. A comprehensive assessment of urinary iodine concentration and thyroid hormones in New Zealand schoolchildren: a cross-sectional study. Nutr J 2012; 11: 31. (7 pages).

Dei-Tutu SA, Manful A, Heimburger DC, Malechi H, Moore DJ, Oppong SA, et al. Correlating maternal iodine status with neonatal thyroid function in two hospital populations in Ghana: a multicenter cross-sectional pilot study. BMC Pediatr 2020; 20: 26. (9 pages).

Vandevijvere S, Coucke W, Vanderpas J, Trumpff C, Fauvart M, Meulemans A, et al. Neonatal thyroid-stimulating hormone concentrations in Belgium: a useful indicator for detecting mild iodine deficiency? PLoS One 2012; 7(10): e47770. (6 pages).

Maahs DM, Zeitler P. Newborn screening in the United States may miss mild persistent hypothyroidism. J Pediatr 2018; 192: 1-2.

Di Dalmazi G, Carlucci MA, Semeraro D, Giuliani C, Napolitano G, Caturegli P, et al. A detailed analysis of the factors influencing neonatal TSH: Results from a 6-year congenital hypothyroidism screening program. Front Endocrinol 2020; 11: 456. (11 pages).

Rajatanavin R. Iodine deficiency in pregnant women and neonates in Thailand. Public Health Nutr 2007; 10(12A): 1602-5.

Burns R, Mayne PD, O’Herlihy C, Smith DF, Higgins M, Staines A, et al. Can neonatal TSH screening reflect trends in population iodine intake? Thyroid 2008; 18(8): 883-8.

Gruñeiro-Papendieck L, Chiesa A, Mendez V, Bengolea S, Prieto L. Neonatal TSH levels as an index of iodine sufficiency: differences related to time of screening sampling and methodology. Horm Res 2004; 62(6): 272-6.

ประกาศคณะกรรมการหลักประกันสุขภาพแห่งชาติเรื่อง ประเภทและขอบเขตของบริการสาธารณสุข พ.ศ. 2565. ราชกิจจานุเบกษา เล่ม 139 ตอนพิเศษ 127 ง (วันที่ 7 มิถุนายน 2565). หน้า 21.

Downloads

Published

26-12-2023

How to Cite

1.
Thaisri H, Krasao P, Thong-ngao P, Nammoonnoy S, Kornsiripanya T, Viriyautsahakul N, Chongchaithe N, Supanuwat J, Mahasirimongkol S. The Correlation between Newborn Thyroid Stimulating Hormone with Maternal Urine Iodine Levels and the Assessment of Iodine Status in the Population during 2019: The Correlation between Newborn Thyruid Stimulating Hormone with Maternal Urine Iodine Levels. ว กรมวิทย พ [internet]. 2023 Dec. 26 [cited 2025 Dec. 27];65(4):237-4. available from: https://he02.tci-thaijo.org/index.php/dmsc/article/view/264206

Issue

Section

Original Articles